The company's financial position reflects significant retrenchment, with total assets contracting from $1.8 billion in 2023Q4 to $514.7 million in 2026Q1, alongside a debt-to-equity ratio of 0.89.
| Total Current Assets | 233.31M | 257.61M | 370.17M | 380.44M | 413.75M | 444.23M | 63.84M | 36.11M |
| Cash & Short-Term Investments | 178.09M | 180.89M | 290.16M | 308.07M | 331.87M | 387.5M | 24.77M | 8.62M |
| Cash Only | 157.65M | 163.63M | 105.38M | 130.98M | 146.93M | 387.5M | 24.77M | 8.62M |
| Short-Term Investments | 20.45M | 17.26M | 184.79M | 177.09M | 184.94M | 0 | 0 | 0 |
| Accounts Receivable | 39.36M | 51.98M | 53.23M | 59.25M | 58.8M | 43.34M | 33.11M | 25.02M |
| Days Sales Outstanding | 62.72 | 78.55 | 77.04 | 86.02 | 96.39 | 95.2 | 102.14 | 106.81 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - |
| Other Current Assets | 155K | 24.74M | 26.78M | 13.12M | 23.07M | 6.88M | 2.95M | 769K |
| Total Non-Current Assets | 281.42M | 477.89M | 719.22M | 1.43B | 1.71B | 1.67B | 1.68B | 1.69B |
| Property, Plant & Equipment | 18.68M | 18.07M | 11.31M | 14.06M | 14.14M | 5.07M | 3.25M | 2.56M |
| Fixed Asset Turnover | 13.30x | 13.36x | 22.30x | 17.88x | 15.74x | 32.78x | 36.43x | 33.43x |
| Goodwill | 0 | 197.22M | 393.28M | 1.08B | 1.32B | 1.26B | 1.26B | 1.23B |
| Intangible Assets | 235.43M | 247.48M | 297.93M | 323.12M | 350.72M | 352.47M | 410.24M | 446.38M |
| Long-Term Investments | 949K | 0 | 0 | 509K | 0 | 32.67M | 5.95M | 0 |
| Other Non-Current Assets | 26.76M | 15.12M | 16.69M | 19.2M | 19.28M | 19.94M | 472K | 2.72M |
| Total Assets | 514.74M | 735.49M | 1.09B | 1.83B | 2.12B | 2.12B | 1.75B | 1.72B |
| Asset Turnover | 0.34x | 0.33x | 0.23x | 0.14x | 0.10x | 0.08x | 0.07x | 0.05x |
| Asset Growth % | -150.75% | -32.49% | -40.34% | -13.98% | 0.24% | 21.33% | 1.41% | - |
| Total Current Liabilities | 140.4M | 156.79M | 161.16M | 170.68M | 140.61M | 123.12M | 88.72M | 69.92M |
| Accounts Payable | 6.02M | 3.6M | 10.76M | 5.79M | 3.95M | 4.65M | 5.66M | 2.16M |
| Days Payables Outstanding | 36.39 | 22.53 | 71.78 | 44.49 | 33.81 | 41.72 | 67.83 | 18.29 |
| Short-Term Debt | 11.41M | 11.43M | 13.75M | 13.75M | 8.59M | 6.88M | 4.68M | 4.5M |
| Deferred Revenue (Current) | 388.9M | 96.99M | 93.34M | 97.38M | 99.69M | 83.61M | 61.64M | 45.98M |
| Other Current Liabilities | 16.73M | 44.77M | 25.21M | 38.72M | 3.16M | 2.97M | 2.08M | 338K |
| Current Ratio | 1.66x | 1.64x | 2.30x | 2.23x | 2.94x | 3.61x | 0.72x | 0.52x |
| Quick Ratio | 1.66x | 1.64x | 2.30x | 2.23x | 2.94x | 3.61x | 0.72x | 0.52x |
| Cash Conversion Cycle | 26.33 | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 183.64M | 199.71M | 321.03M | 456.05M | 500.07M | 494.66M | 461.07M | 435M |
| Long-Term Debt | 153.99M | 161.24M | 229.37M | 242.57M | 255.76M | 263.81M | 457.2M | 434.85M |
| Capital Lease Obligations | 21.87M | 5.15M | 7.59M | 9.37M | 9.97M | 0 | 0 | 0 |
| Deferred Tax Liabilities | 54.56M | 14.63M | 25.09M | 67.16M | 75.74M | 76.4M | 0 | 0 |
| Other Non-Current Liabilities | 14M | 16.31M | 58.96M | 136.93M | 158.36M | 154.04M | 3.74M | 0 |
| Total Liabilities | 324.04M | 356.5M | 482.19M | 626.73M | 640.68M | 617.78M | 549.8M | 504.91M |
| Total Debt | 169.84M | 177.82M | 253.11M | 267.93M | 275.85M | 270.68M | 461.88M | 439.35M |
| Net Debt | 12.19M | 14.19M | 147.73M | 136.95M | 128.91M | -116.81M | 437.1M | 430.73M |
| Debt / Equity | 0.89x | 0.47x | 0.42x | 0.22x | 0.19x | 0.18x | 0.39x | 0.36x |
| Debt / EBITDA | 0.81x | 11.67x | - | - | 21.45x | 8.30x | 10.57x | 14.01x |
| Net Debt / EBITDA | 0.06x | 0.93x | - | - | 10.02x | -3.58x | 10.00x | 13.73x |
| Interest Coverage | -3.42x | -17.54x | -41.71x | -19.27x | -2.74x | -1.42x | -0.44x | -0.98x |
| Total Equity | 190.7M | 378.99M | 607.19M | 1.2B | 1.48B | 1.5B | 1.2B | 1.22B |
| Equity Growth % | -191.41% | -37.58% | -49.37% | -19.08% | -1.19% | 25.45% | -1.7% | - |
| Book Value per Share | 1.82 | 3.55 | 5.21 | 10.63 | 14.66 | 15.46 | 12.32 | 8.16 |
| Total Shareholders' Equity | 146.23M | 281.11M | 444.38M | 861.36M | 948.92M | 871.31M | 1.2B | 1.22B |
| Common Stock | 105K | 104K | 114K | 117K | 105K | 97K | 1.31B | 1.27B |
| Retained Earnings | -918.13M | -779.51M | -640.57M | -227.45M | -25.06M | -17.84M | -109.86M | -55.76M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1.55M | -1.45M | -610K | 2.11M | 3.67M | 62K | -131K | 0 |
| Minority Interest | 44.47M | 97.88M | 162.82M | 337.82M | 533.03M | 628.52M | 0 | 0 |
Persistent Revenue Contraction
As reported in financial statements, Definitive Healthcare’s total assets have declined from $1.8 billion in 2023Q4 to $514.7 million in 2026Q1, reflecting a significant reduction in the company’s balance sheet footprint that appears to correlate with ongoing challenges in maintaining top-line growth and operational scale.
The sharp reduction in total assets, largely driven by the impairment or write-down of goodwill, suggests that previous acquisition-led growth strategies are being reassessed. Investors should monitor whether this contraction represents a necessary rightsizing of the business or a more concerning erosion of the company's competitive infrastructure.
Based on the provided quarterly data, goodwill has plummeted from $1.1 billion in 2023Q4 to $235.4 million in 2026Q1, indicating that the carrying value of past acquisitions is being aggressively adjusted downward to reflect current market realities and the company's diminished growth prospects.
The concentration of assets in intangible form historically masked the true economic value of the platform, and the recent write-downs suggest that the premium paid for historical growth is no longer supported by current performance. This shift implies that the asset base is becoming less reliant on acquisition-driven intangibles and more focused on the underlying data platform.
According to recent SEC filings, Definitive Healthcare’s retained earnings have deteriorated significantly, reaching a deficit of $918.1 million in 2026Q1, which highlights the persistent impact of cumulative net losses on the company’s total equity position over the last ten quarters.
The consistent expansion of the retained earnings deficit suggests that the business model has yet to reach a point of self-sustaining profitability. This trend warrants further investigation into whether the current equity structure can support future operational needs without requiring further dilution or external financing.
As reported in financial statements, the company maintains a cash position of $157.6 million as of 2026Q1, providing a liquidity buffer that appears adequate for near-term operations despite the ongoing pressure from negative net margins and the lack of consistent free cash flow generation.
While the current ratio of 1.66 suggests sufficient short-term liquidity, the reliance on cash reserves to fund operations is a critical vulnerability. Investors should monitor the burn rate closely, as the absence of positive cash flow from operations may eventually necessitate a pivot in capital allocation strategy.
Based on reported figures, Definitive Healthcare maintains a debt-to-equity ratio of 0.89 as of 2026Q1, which, while higher than historical levels, suggests that the company has not yet resorted to aggressive debt financing to offset its persistent operational deficits.
The company’s debt profile appears manageable in the context of its current cash position, yet the rising D/E ratio reflects the shrinking equity base rather than an increase in absolute debt. This suggests that management is maintaining a conservative leverage profile, which may be a strategic choice to preserve flexibility.
Quick answers to the most common questions about buying DH stock.
As of 2025, Definitive Healthcare Corp. (DH) had total assets of $735.5M including $257.6M in current assets.
Definitive Healthcare Corp. (DH) carries total debt of $177.8M, offset by $180.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Definitive Healthcare Corp. (DH) has total shareholders' equity (book value) of $281.1M ($3.55 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Definitive Healthcare Corp. (DH) reported a current ratio of 1.64x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.